PT - JOURNAL ARTICLE AU - Mika Naganawa AU - Nabeel Nabulsi AU - Shannan Henry AU - David Matuskey AU - Shu-Fei Lin AU - Lawrence Slieker AU - Adam J. Schwarz AU - Nancy Kant AU - Cynthia Jesudason AU - Kevin Ruley AU - Antonio Navarro AU - Hong Gao AU - Jim Ropchan AU - David Labaree AU - Richard E. Carson AU - Yiyun Huang TI - First-in-Human Assessment of <sup>11</sup>C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer AID - 10.2967/jnumed.120.246967 DP - 2021 Apr 01 TA - Journal of Nuclear Medicine PG - 553--560 VI - 62 IP - 4 4099 - http://jnm.snmjournals.org/content/62/4/553.short 4100 - http://jnm.snmjournals.org/content/62/4/553.full SO - J Nucl Med2021 Apr 01; 62 AB - This was a first-in-human study of the PET radiotracer 11C-LSN3172176 for the muscarinic acetylcholine receptor subtype M1. The objectives of the study were to determine the appropriate kinetic model to quantify binding of the tracer to M1 receptors, and the reliability of the chosen quantification method. Methods: Six healthy subjects completed the test–retest protocol, and 5 healthy subjects completed the baseline-scopolamine blocking protocol. Multiple modeling methods were applied to calculate total distribution volume (VT) and nondisplaceable binding potential (BPND) in various brain regions. The reference region was selected from the blocking study. The occupancy plot was applied to compute receptor occupancy by scopolamine and nondisplaceable distribution volume. Results: Tracer uptake was highest in the striatum, followed by neocortical regions and white matter, and lowest in the cerebellum. Regional time–activity curves were fitted well by all models. The 2-tissue-compartment (2TC) model fits were good, but the 2TC parameters often could not be reliably estimated. Because VT correlated well between the 2TC and 1-tissue-compartment (1TC) models after exclusion of unreliable estimates, the 1TC model was chosen as the most appropriate. The cerebellum showed the lowest VT, consistent with preclinical studies showing little to no specific binding in the region. Further, cerebellar VT did not change between baseline and blocking scans, indicating that the cerebellum is a suitable reference region. The simplified reference tissue model (SRTM) slightly underestimated 1TC BPND, and the simplified reference tissue model 2 (SRTM2) improved BPND estimation. An 80-min scan was sufficient to quantify VT and BPND. The test–retest study showed excellent absolute test–retest variability for 1TC VT (≤5%) and BPND (≤10%). In the baseline and blocking studies, occupancy values were lower in the striatum than in nonstriatal regions, as may be attributed to differences in regional acetylcholine concentrations. Conclusion: The 1TC and SRTM2 models are appropriate for quantitative analysis of 11C-LSN3172176 imaging data. 11C-LSN3172176 displayed excellent test–retest reproducibility and is a highly promising ligand to quantify M1 receptors in the human brain.